Literature DB >> 12204148

Drug use, travel and HIV risk.

D Lee1, D C Bell, M Hinojosa.   

Abstract

A study was conducted to examine the travel experiences of a community sample of 160 drug users and 44 non-users recruited as part of a study of HIV risk. Of the sample, 47% (96/204) reported intercity travel in the previous ten years. Results showed that men were more likely to travel than women, Anglos more than minorities, and young persons more than old. When travellers testing HIV-seropositive (n = 13) were compared with seronegative travellers, HIV-positive travellers reported more sex while travelling than HIV-negative persons, but virtually all of the difference reported involved sex with condoms. There were no significant differences in sex risk behaviours while travelling between drug users and non-drug users, or in sex risk behaviors between drug injectors and non-injectors. Travellers had fewer injection partners while travelling than they had while at home. There was also a significant difference in number of sex partners with whom a condom was not used, with fewer sex partners while travelling.

Entities:  

Mesh:

Year:  2002        PMID: 12204148     DOI: 10.1080/09540120208629664

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  3 in total

1.  Prevalence and Correlates of Injecting with Visitors from the United States Among People Who Inject Drugs in Tijuana, Mexico.

Authors:  A Bórquez; R S Garfein; D Abramovitz; L Liu; L Beletsky; D Werb; S R Mehta; G Rangel; C Magis-Rodríguez; P González-Zúñiga; S A Strathdee
Journal:  J Immigr Minor Health       Date:  2019-12

2.  A qualitative exploration of travel-related risk behaviours of injection drug users from two Slovene regions.

Authors:  Tatja Kostnapfel; Igor Svab; Danica P Rotar
Journal:  Harm Reduct J       Date:  2011-04-17

3.  HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.

Authors:  Thu Minh T Tran; Hien T Nguyen; Hiroshi Yatsuya; Nobuyuki Hamajima; Akio Nishimura; Katsuki Ito
Journal:  BMC Public Health       Date:  2006-10-10       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.